(188 days)
The M-50 Series SpO2 Sensor is intended for spot checking or continuous monitoring of functional arterial oxygen saturation and pulse rate in non-invasive with oximeter equipment.
The M-50A, M-50E and M-50G SpO2 Sensor is intended for adult patients in hospitals, hospital-type facilities, and home environments.
The M-50B and M-50H SpO2 Sensor is intended for pediatric patients in hospitals, hospital-type facilities, and home environments.
The M-50C SpO2 Sensor is intended for adult, pediatric, infant and neonatal patients in hospitals, hospital-type facilities, and home environments.
The applicant sensor M-50 Series SpO2 Sensors measure, non-invasively, the arterial oxygen saturation of blood. The measurement method is based on the red and infrared light absorption of hemoglobin and oxyhemoglobin. Light of a red and infrared light source is emitted through human tissue and received by a photodiode.
The measurement is based on the absorption of light, which is emitted through human tissue (for example through the index finger). The light comes from two sources (red LED and infrared LED) with different wavelengths and is received by a photodiode. Out of the different absorption behavior of the red and infrared light a so-called ratio can be calculated. The saturation value is defined by the percentage ratio of the oxygenated hemoglobin [HbO2] to the total amount of hemoglobin [Hb].
SpO2 = [HbO2]/([Hb+[HbO2]]
Those sensors contain a red and infrared light source and a photodiode receiving the non-absorbed red and infrared light. The received signals are forwarded to a measurement device that amplifies the acquired signal and an algorithm that calculates the ratio and converts via a validated calibration table the ratio to a saturation value.
The model M-50A and M-50B sensors are the accessory of legally marketed device MD300I ( K072825 ).
All of the sensors included in applicant M-50 Series SpO2 sensors have the identical materials , electro-optical components and basic technical specification.
The model M-50A,M-50B and M-50E sensor use the same configuration manner as the finger clip. All the clip sensors ( M-50A, M-50E) composed by two sorts of material, the enclosure's material of the sensor is ABS, and the material of another part which contact with patient skin, we call that " silica gel cushion", is Medical Silicon
The model M-50C use a sort of configuration manner as binding manner. The M-50C just have single material as the Medical Silicon.
The model M-50G and M-50H use the same configuration manner as the fingertip. Because of the fingertip sensor just have single material as the Medical Silicon, so they are soft.
The applicant sensors are not for implant. Those sensors are not sterile and do not need sterilization or re-sterilization. The device is for prescription. The device does not contain drug or biological product.
The device is electrically operated and the electrical safety and electromagnetic compatibility following IEC 60601-1 and IEC60601-1-2 were conducted.
The device is not software-driven.
A11 the information about the device performance was according to the FDA guidance.
The Clinical Test Report following ISO 9919:2005, Medical electrical equipment- Particular requirements for the basic safety and essential performance of pulse oximeter equipment for medical use are conducted.
- Acceptance Criteria and Reported Device Performance:
The provided document describes the M-50 Series SpO2 Sensor as being substantially equivalent to a predicate device (MD300I, K072825). The acceptance criteria for the M-50 Series SpO2 Sensor models are not explicitly described with numerical thresholds in the provided text. However, the document states:
- "The Clinical Test Report following ISO 9919:2005, Medical electrical equipment- Particular requirements for the basic safety and essential performance of pulse oximeter equipment for medical use are conducted."
- "The result of neonate clinical trial is meet the requirements of FDA Pulse Oximeter Guidance."
This implies that the device performance was measured and found to comply with the performance standards outlined in ISO 9919:2005 and FDA Pulse Oximeter Guidance. Without direct access to these reports or the specific guidance documents, the precise numerical acceptance criteria and reported performance cannot be extracted.
Table of Acceptance Criteria and Reported Device Performance (Inferred):
| Acceptance Criteria (Inferred from ISO 9919:2005 & FDA Guidance) | Reported Device Performance (Inferred from study conclusion) |
|---|---|
| Compliance with ISO 9919:2005 for basic safety and essential performance of pulse oximeter equipment for medical use. | The clinical test report confirmed compliance. |
| Meeting requirements of FDA Pulse Oximeter Guidance for neonate use (for M-50C). | The neonate clinical trial results met requirements. |
- Sample size used for the test set and the data provenance:
The document mentions "Clinical Test Report following ISO 9919:2005" and "neonate clinical trial." However, the exact sample sizes for these test sets are not specified in the provided text.
The data provenance is also not explicitly stated beyond the mention of "Clinical Test Report" and "neonate clinical trial." It is not clear if the studies were retrospective or prospective, or the country of origin of the data.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not provided in the given text.
- Adjudication method for the test set:
This information is not provided in the given text.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
The device described is an SpO2 sensor, which non-invasively measures arterial oxygen saturation. It is a standalone medical device and not an AI-assisted diagnostic tool for human readers. Therefore, an MRMC comparative effectiveness study involving human readers and AI assistance is not applicable and not mentioned.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
Yes, a standalone study was done. The document states, "AII the information about the device performance was according to the FDA guidance. The Clinical Test Report following ISO 9919:2005, Medical electrical equipment- Particular requirements for the basic safety and essential performance of pulse oximeter equipment for medical use are conducted." This refers to performance testing of the device itself, which operates as an algorithm calculating SpO2 values without direct human intervention in the calculation process. Additionally, a "neonate clinical trial" was conducted to demonstrate safety and effectiveness for neonate use of the M-50C sensor.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
For pulse oximetry, the ground truth for arterial oxygen saturation is typically established through co-oximetry of arterial blood samples. While the document doesn't explicitly state "co-oximetry," clinical trials for pulse oximeters following ISO 9919:2005 commonly use arterial blood gas analysis with co-oximetry as the reference standard to establish ground truth for SpO2 measurements. The phrase "Clinical Test Report following ISO 9919:2005" implies the use of such accepted methods for ground truth establishment.
- The sample size for the training set:
This information is not provided in the given text. The device's operation is based on a "validated calibration table" and an "algorithm that calculates the ratio and converts via a validated calibration table the ratio to a saturation value," rather than a continuously learning AI model with a distinct "training set" in the modern machine learning sense. The calibration table would have been developed using a set of data, but this is not referred to as a "training set."
- How the ground truth for the training set was established:
As mentioned above, the device uses a "validated calibration table" rather than a training set for a machine learning model. The method for establishing the ground truth for this calibration table is not explicitly detailed in the provided text, but it would typically involve
comparing the device's optical absorbance ratio measurements against arterial blood gas co-oximetry readings from various subjects with different oxygen saturation levels.
{0}------------------------------------------------
4 2009 MAR
Chapter III 510(k) Summary
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 9807.92.
The Assigned 510(k) Number is:
1. Applicant Device Information
Device Common Name: SpO2 Pulse Oximeter sensor Device Trade/Proprietary Name: M-50 Series SpO2 Sensor Models M-50A;M-50B;M-50C;M-50E;M-50G;M-50H
Classification Information:
- Classification Name: Oximeter (1)
- Regulation Number:870.2700 (2)
- Product Code: DQA (3)
- Class: II (4)
- Review Panel: Anesthesiology (5)
-
- Submitter Information
Manufacturer Name and Address
Beijing Choice Electronic Technology Co., Ltd. Room 1127-1128 Building B, Bailangyuan Fuxing Road , No. A36 Beijing, China 100039
Contact Person of the Submission
Mr. Chen Lei Ms. Li Yajing North Building 3F, No.9 Shuangyuan Road Badachu Hi-tech Zone,Shijingshan District Beijing China 100041 Phone: +86-10-88790480 x 6046 Fax:+86-10-88798860 Email: liyajing@choicemmed.com
{1}------------------------------------------------
3. Predicate Device
M-50A SpO2 Sensor (legally market as the accessory of pulse oximter MD300I@K072825)
Manufactured by:
Beijing Choice Electronic Technology Co., Ltd. Room 1127-1128 Building B, Bailangyuan Fuxing Road , No. A36 Beijing, China 100039
4. Device Description
The applicant sensor M-50 Series SpO2 Sensors measure, non-invasively, the arterial oxygen saturation of blood. The measurement method is based on the red and infrared light absorption of hemoglobin and oxyhemoglobin. Light of a red and infrared light source is emitted through human tissue and received by a photodiode.
The measurement is based on the absorption of light, which is emitted through human tissue (for example through the index finger). The light comes from two sources (red LED and infrared LED) with different wavelengths and is received by a photodiode. Out of the different absorption behavior of the red and infrared light a so-called ratio can be calculated. The saturation value is defined by the percentage ratio of the oxygenated hemoglobin [HbO2] to the total amount of hemoglobin [Hb].
SpO2 = [HbO2]/([Hb+[HbO2]]
Those sensors contain a red and infrared light source and a photodiode receiving the non-absorbed red and infrared light. The received signals are forwarded to a measurement device that amplifies the acquired signal and an algorithm that calculates the ratio and converts via a validated calibration table the ratio to a saturation value.
The model M-50A and M-50B sensors are the accessory of legally marketed device MD300I ( K072825 ).
All of the sensors included in applicant M-50 Series SpO2 sensors have the identical materials , electro-optical components and basic technical specification.
The model M-50A,M-50B and M-50E sensor use the same configuration manner as the finger clip. All the clip sensors ( M-50A, M-50E) composed by two sorts
{2}------------------------------------------------
of material, the enclosure's material of the sensor is ABS, and the material of another part which contact with patient skin, we call that " silica gel cushion", is Medical Silicon
The model M-50C use a sort of configuration manner as binding manner. The M-50C just have single material as the Medical Silicon.
The model M-50G and M-50H use the same configuration manner as the fingertip. Because of the fingertip sensor just have single material as the Medical Silicon, so they are soft.
The applicant sensors are not for implant. Those sensors are not sterile and do not need sterilization or re-sterilization. The device is for prescription. The device does not contain drug or biological product.
The device is electrically operated and the electrical safety and electromagnetic compatibility following IEC 60601-1 and IEC60601-1-2 were conducted.
The device is not software-driven.
A11 the information about the device performance was according to the FDA guidance.
The Clinical Test Report following ISO 9919:2005, Medical electrical equipment- Particular requirements for the basic safety and essential performance of pulse oximeter equipment for medical use are conducted.
5. Intended Use
The M-50 Series SpO2 Sensor is intended for spot checking or continuous monitoring of functional arterial oxygen saturation and pulse rate in non-invasive with oximeter equipment..
The M-50A.M-50E and M-50G SpO2 Sensor is intended for adult patients in hospitals, hospital-type facilities, and home environments.
The M-50B and M-50H SpO2 Sensor is intended for pediatric patients in hospitals, hospital-type facilities, and home environments.
The M-50C SpO2 Sensor is intended for adult, pediatric, infant and neonatal patients in hospitals, hospital-type facilities, and home environments.
The BCI3301 and 3303 oximeters will be intended for use with the M-50 Series SpO2
{3}------------------------------------------------
Sensor.
6. Substantially Equivalence Determination
Comparison Analysis
Because of the SpO2 sensor M-50A of M-50 series is accessory of predicate device (MD300I), so they have same sensor aspect between them. The mainly difference is the difference between each sensor in M-50 series SpO2 sensor. Each sensor of M-50 series has same classification information, specification, material and safety and effectiveness. The mainly difference is exhibit as Intended use population and configuration.
The mainly difference of intended use population is the intended use of M-50C, which includes neonate use, for this intended use, we provide the clinical trial report to demonstrate the safety and effectiveness of the product. The result of neonate clinical trial is meet the requirements of FDA Pulse Oximeter Guidance.
The configuration of each SpO2 sensor of M-50 series is another difference, although the appearance and configuration manner are different but the material of each sensor are same.
Conclusion
The applicant device is Substantially Equivalent (SE) to the predicate device which is US legally market device. Therefore, the applicant device is determined as safe and effectiveness.
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird-like figure with three curved lines forming its body and wings. The logo is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
MAR 4 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Chen Lei Beijing Choice Electronic Technology Company, Limited Room 1127-1128 Building B, Bailangyuan Fuxing Road, No. A36 Beijing China 100039
Re: K082487
Trade/Device Name: M-50 Series SpO2 Sensor, Models M50-A;M-50B;M-50C; M-50E;M-50G,M-50H Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DOA Dated: March 2, 2009 Received: March 2, 2009
Dear Mr. Lei:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{5}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Suiste Y. Mickan Oues.
Ginette Y. Michaud, M.D. Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Indication for Use
510(k) Number (if known):
Device Name: M-50 Series SpO2 Sensor, Models M50-A;M-50B;M-50C;M-50E;M-50G;M-50H
Indications for Use:
The M-50 Series SpO2 Sensor is intended for spot checking or continuous monitoring of functional arterial oxygen saturation and pulse rate in non-invasive with oximeter equipment.
The M-50A, M-50E and M-50G SpO2 Sensor is intended for adult patients in hospitals, hospital-type facilities, and home environments.
The M-50B and M-50H SpO2 Sensor is intended for pediatric patients in hospitals, hospital-type facilities, and home environments.
The M-50C SpO2 Sensor is intended for adult, pediatric, infant and neonatal patients in hospitals, hospital-type facilities, and home environments.
Prescription Use __ V (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Sutta Y. Michain D.D.S.
(Division Sign-Off)
Division of Anesthesiology, General Hospital
Infection Control, Dental Devices
Page 1 of 1
510(k) Number: K082487
II-2
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).